ArticleCell death & disease2025

Loss of ELF2 drives topotecan resistance in retinoblastoma revealed by genome-wide CRISPR-Cas9 screening.

Jingyi Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.